Drugs / [18F]PGM299
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02716987 | Mar → Aug 2016 | — | Neurocrine Biosciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]PGM299 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02716987 ↗ |
| Modality | Diagnostic / imaging agent | “[18F]PGM299 radioactive tracer injection and PET imaging” NCT02716987 ↗ |